Patents by Inventor Kurt Schromm

Kurt Schromm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
    Publication number: 20030092704
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I 1
    Type: Application
    Filed: September 5, 2002
    Publication date: May 15, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Kurt Schromm, Horst Dollinger, Birgit Jung, Georg Speck
  • Pyranoside derivatives
    Patent number: 6528491
    Abstract: The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them as well as their use as medicaments:
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: March 4, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
    Patent number: 6498162
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I and the pharmaceutically acceptable salts thereof, wherein R1 and R2 together with the N to which they are bound form a ring of the formula in which R3, R4, R5, Ar, R6, R7, R8, R9, R10, R11, r, s and t have the meanings given in the specification and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: December 24, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Kurt Schromm, Horst Dollinger, Birgit Jung, Georg Speck
  • Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect
    Patent number: 6489365
    Abstract: Compounds of the formula which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: December 3, 2002
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Frank Himmelsbach, Franz Birke, Armin Fugner
  • Sulphoxybenzamides
    Patent number: 6489359
    Abstract: The present invention relates to new sulphoxybenzamides of general formula I, processes for preparing them as well as their use as medicaments.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: December 3, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Sulphoxybenzamides
    Publication number: 20020161043
    Abstract: The present invention relates to new sulphoxybenzamides of general formula I, processes for preparing them as well as their use as medicaments.
    Type: Application
    Filed: October 23, 2001
    Publication date: October 31, 2002
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Neurokinin antagonists
    Publication number: 20020147219
    Abstract: The invention relates to new compounds of formula I 1
    Type: Application
    Filed: October 16, 2001
    Publication date: October 10, 2002
    Inventors: Horst Dollinger, Franz Esser, Birgit Jung, Kurt Schromm, Georg Speck
  • Pyranoside derivatives
    Publication number: 20020128209
    Abstract: The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them as well as their use as medicaments.
    Type: Application
    Filed: October 23, 2001
    Publication date: September 12, 2002
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Neurokinin antagonists
    Publication number: 20020115666
    Abstract: The invention relates to new compounds of formula I 1
    Type: Application
    Filed: October 16, 2001
    Publication date: August 22, 2002
    Inventors: Horst Dollinger, Franz Esser, Birgit Jung, Gerd Schnorrenberg, Kurt Schromm, Georg Speck
  • Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments
    Publication number: 20020022625
    Abstract: A compound of formula 1 1
    Type: Application
    Filed: April 18, 2001
    Publication date: February 21, 2002
    Inventors: Alexander Walland, Kurt Schromm, Karl-Heinz Bozung, Herman Schollenberger
  • Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
    Patent number: 6288277
    Abstract: The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 11, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6265612
    Abstract: The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: July 24, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6197824
    Abstract: Novel benzamidines, having LTB4-antagonistic activity, of the formula methods for their preparation, their and their use as medicaments.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Pyranoside derivatives
    Patent number: 6197753
    Abstract: Pyranoside derivatives of the formula I wherein 1, m and n independently of one another denote an integer chosen from 0, 1, 2, 3 and 4 and 1+m+n≦4. These are are LTB4-antagonists. Also disclosed are processes for making these compounds.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans M. Jennewein, Christopher J. M. Meade, Andreas Ding
  • Phenylamidine derivatives, a process for preparing the same and their use as medicaments
    Patent number: 6127423
    Abstract: The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 3, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade, Andreas Ding
  • Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
    Patent number: 6037377
    Abstract: Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 14, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Frank Himmelsbach, Franz Birke, Armin Fugner
  • Substituted benzamidine compounds which have useful pharmaceutical activity
    Patent number: 5731332
    Abstract: Compounds of formula ##STR1## and their therapeutic use, inter alia, as LTB.sub.4 -antagonists. Exemplary compounds are:(Methoxycarbonyl-imino-{4'-?2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-meth yl)-amine;(Benzyloxycarbonyl-imino-{4'-?2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-me thyl-amine;?Hydroxy-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy} phenyl)-methyl!-amine;?Ethoxycarbonyl-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benz oyloxy}phenyl)-methyl!-amine; and,?3'-Pyridylcarbonyl-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!- benzyloxy}phenyl)-methyl!-amine.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: March 24, 1998
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Armin Fugner, Hubert Heuer, Christopher Meade
  • Chemical compound, the preparation thereof and its use in pharmaceutical compositions
    Patent number: 5686496
    Abstract: The new compound of formula ##STR1## may be prepared by conventional methods and used therapeutically as an LTB.sub.4 -receptor antagonist.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: November 11, 1997
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Armin Fugner, Hubert Heuer, Christopher Meade
  • Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection
    Patent number: 5571806
    Abstract: Disclosed is the use of dibenz[b,f][1,4]oxazepin (or thiazepin)-11(10H)-ones and -thiones in the prevention and treatment of AIDS, ARC and related disorders associated with HIV infection.
    Type: Grant
    Filed: July 6, 1994
    Date of Patent: November 5, 1996
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Karl D. Hargrave, Gunther Schmidt, deceased, Wolfhard Engel, Kurt Schromm
  • New quaternary ammonium compounds, their preparation and use
    Patent number: 5223614
    Abstract: Compounds of formula ##STR1## wherein the substituents are defined hereinbelow, useful in the treatment of bronchospasm are described.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: June 29, 1993
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Kurt Schromm, Anton Mentrup, Ernst-Otto Renth, Gojko Mualcevic, Werner Traunecker